All In MedTech

FDA Clearance Tracker · P960009-S514

Activa™ Deep Brain Stimulation Therapy System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 17, 2025

Approved

Time to decision

149 days

Received Jul 21, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960009-S514
Device name
Activa™ Deep Brain Stimulation Therapy System
Applicant location
Minneapolis, MN
Received
Jul 21, 2025
Decided
Dec 17, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

approval for using real-world evidence (RWE) from the Medtronic Registry for Epilepsy (MORE registry) as an alternative approach for the Epilepsy Post- Approval Study (EPAS study, P960009/S433) to meet the conditions of approval outlined in the FDA approval order for P960009/S219

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.